Author

W. Phung

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. ElSohly· 1 shared C. Eidenschenk· 1 shared C. Everett· 1 shared C. Lu· 1 shared C. Mullen· 1 shared C. Tsai· 1 shared D. Arnott· 1 shared D. DiCara· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. ElSohly

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Exposing the molecular heterogeneity of glycosylated biotherapeutics

L. F. Schachner, C. Mullen, W. Phung, J. D. Hinkle, M. I. Beardsley, T. Bentley, P. Day, C. Tsai, S. Sukumaran, T. Baginski, D. DiCara, N. Agard, M. Masureel, J. Gober, A. ElSohly, , W. Sandoval

This paper introduces a new method for analyzing glycoform heterogeneity in biotherapeutics using mass spectrometry and bioinformatics, showing its effectiveness in measuring proteoform diversity and correlating glycoform sub-populations with pharmacological properties.

bioRxiv · May 10, 2023Biochemistry

Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunity

R. Barreira da Silva, R. Leitao, X. Pechuan, S. Werneke, J. Oeh, V. Javinal, Y. Wang, W. Phung, C. Everett, J. Nonomiya, D. Arnott, C. Lu, Y.-C. Hsiao, J. T. Koerber, I. Hotzel, , M. Albert

This study shows that QPCTL inhibition reduces monocyte migration and alters myeloid cell infiltration, enhancing anti-tumor immunity when combined with anti-PD-L1 therapy.

bioRxiv · Jan 25, 2022Immunology